chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Decreased appetite, Dyspnoea, Limb discomfort, Malaise
Clinical narrative: Redness on arm; Soreness; Hard time breathing; Squeaking to breath; No taste buds; No appetite, loss 9 pounds; Felt like she had covid; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness on arm), LIMB DISCOMFORT (Soreness), DYSPNOEA (Hard time breathing), WHEEZING (Squeaking to breath) and AGEUSIA (No taste buds) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced DYSPNOEA (Hard time breathing), WHEEZING (Squeaking to breath), AGEUSIA (No taste buds), DECREASED APPETITE (No appetite, loss 9 pounds) and MALAISE (Felt like she had covid). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness on arm) and LIMB DISCOMFORT (Soreness). At the time of the report, VACCINATION SITE ERYTHEMA (Redness on arm), LIMB DISCOMFORT (Soreness), DYSPNOEA (Hard time breathing), WHEEZING (Squeaking to breath), AGEUSIA (No taste buds), DECREASED APPETITE (No appetite, loss 9 pounds) and MALAISE (Felt like she had covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Wheezing
Clinical narrative: Redness on arm; Soreness; Hard time breathing; Squeaking to breath; No taste buds; No appetite, loss 9 pounds; Felt like she had covid; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness on arm), LIMB DISCOMFORT (Soreness), DYSPNOEA (Hard time breathing), WHEEZING (Squeaking to breath) and AGEUSIA (No taste buds) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced DYSPNOEA (Hard time breathing), WHEEZING (Squeaking to breath), AGEUSIA (No taste buds), DECREASED APPETITE (No appetite, loss 9 pounds) and MALAISE (Felt like she had covid). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness on arm) and LIMB DISCOMFORT (Soreness). At the time of the report, VACCINATION SITE ERYTHEMA (Redness on arm), LIMB DISCOMFORT (Soreness), DYSPNOEA (Hard time breathing), WHEEZING (Squeaking to breath), AGEUSIA (No taste buds), DECREASED APPETITE (No appetite, loss 9 pounds) and MALAISE (Felt like she had covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Injection site warmth, Nausea, Pain
Clinical narrative: tongue hurt a little bit; fever of 100.2F; chills; nauseous; no appetite; arm turned red to the elbow; arm hurt to the elbow; arm hot to the touch to the elbow; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm turned red to the elbow), VACCINATION SITE PAIN (arm hurt to the elbow), INJECTION SITE WARMTH (arm hot to the touch to the elbow), PYREXIA (fever of 100.2F) and CHILLS (chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm turned red to the elbow), VACCINATION SITE PAIN (arm hurt to the elbow) and INJECTION SITE WARMTH (arm hot to the touch to the elbow). On 16-Jan-2021, the patient experienced PYREXIA (fever of 100.2F), CHILLS (chills), NAUSEA (nauseous) and DECREASED APPETITE (no appetite). On 18-Jan-2021, the patient experienced PAIN (tongue hurt a little bit). On 19-Jan-2021, NAUSEA (nauseous) and DECREASED APPETITE (no appetite) had resolved. On 21-Jan-2021, VACCINATION SITE ERYTHEMA (arm turned red to the elbow), VACCINATION SITE PAIN (arm hurt to the elbow) and INJECTION SITE WARMTH (arm hot to the touch to the elbow) had resolved. On 22-Jan-2021, PYREXIA (fever of 100.2F) and CHILLS (chills) had resolved. On 24-Jan-2021, PAIN (tongue hurt a little bit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: tongue hurt a little bit; fever of 100.2F; chills; nauseous; no appetite; arm turned red to the elbow; arm hurt to the elbow; arm hot to the touch to the elbow; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (arm turned red to the elbow), VACCINATION SITE PAIN (arm hurt to the elbow), INJECTION SITE WARMTH (arm hot to the touch to the elbow), PYREXIA (fever of 100.2F) and CHILLS (chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (arm turned red to the elbow), VACCINATION SITE PAIN (arm hurt to the elbow) and INJECTION SITE WARMTH (arm hot to the touch to the elbow). On 16-Jan-2021, the patient experienced PYREXIA (fever of 100.2F), CHILLS (chills), NAUSEA (nauseous) and DECREASED APPETITE (no appetite). On 18-Jan-2021, the patient experienced PAIN (tongue hurt a little bit). On 19-Jan-2021, NAUSEA (nauseous) and DECREASED APPETITE (no appetite) had resolved. On 21-Jan-2021, VACCINATION SITE ERYTHEMA (arm turned red to the elbow), VACCINATION SITE PAIN (arm hurt to the elbow) and INJECTION SITE WARMTH (arm hot to the touch to the elbow) had resolved. On 22-Jan-2021, PYREXIA (fever of 100.2F) and CHILLS (chills) had resolved. On 24-Jan-2021, PAIN (tongue hurt a little bit) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Myalgia, Pyrexia
Clinical narrative: Cough; Fever; Headache; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Body aches) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Body aches). On 03-Feb-2021, the patient experienced COUGH (Cough). At the time of the report, COUGH (Cough), PYREXIA (Fever), HEADACHE (Headache) and MYALGIA (Body aches) had resolved.            Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up was received on 20 Apr 2021. Outcome of events added.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Tenderness  and soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Tenderness  and soreness at the injection site) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced INJECTION SITE PAIN (Tenderness  and soreness at the injection site). At the time of the report, INJECTION SITE PAIN (Tenderness  and soreness at the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on left arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02AL20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), Anxiety meds, Vitamin pack, ZINC and MELOXICAM for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced RASH (Rash on left arm). At the time of the report, RASH (Rash on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity, Vaccination site pain, Vaccination site swelling
Clinical narrative: pain in the arm of the injection that lasted for a couple of days; some swelling at the injection site for the first couple of days; it has a low grade pain every once in a while.; The arm is uncomfortable , but still can use it; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (it has a low grade pain every once in a while.), LIMB DISCOMFORT (The arm is uncomfortable , but still can use it), VACCINATION SITE PAIN (pain in the arm of the injection that lasted for a couple of days) and VACCINATION SITE SWELLING (some swelling at the injection site for the first couple of days) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (allergic castor oil/creams) and Allergy (Allergic to PEG40). Concomitant products included OMEPRAZOLE, ROPINIROLE and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced PAIN IN EXTREMITY (it has a low grade pain every once in a while.) and LIMB DISCOMFORT (The arm is uncomfortable , but still can use it). On an unknown date, the patient experienced VACCINATION SITE PAIN (pain in the arm of the injection that lasted for a couple of days) and VACCINATION SITE SWELLING (some swelling at the injection site for the first couple of days). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (it has a low grade pain every once in a while.), LIMB DISCOMFORT (The arm is uncomfortable , but still can use it), VACCINATION SITE PAIN (pain in the arm of the injection that lasted for a couple of days) and VACCINATION SITE SWELLING (some swelling at the injection site for the first couple of days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Fatigue, Headache
Clinical narrative: Diarrhea; Fatigue; Joint Pain; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Fatigue), ARTHRALGIA (Joint Pain) and HEADACHE (Headaches) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), FATIGUE (Fatigue), ARTHRALGIA (Joint Pain) and HEADACHE (Headaches). On 11-Jan-2021, DIARRHOEA (Diarrhea), FATIGUE (Fatigue) and ARTHRALGIA (Joint Pain) had resolved. At the time of the report, HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications provided as blood pressure medication and various vitamins. No treatment details was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rashes on trunk (full body), arms and legs; This spontaneous case was reported by a patient and describes the occurrence of RASH (Rashes on trunk (full body), arms and legs) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced RASH (Rashes on trunk (full body), arms and legs). On 17-Feb-2021, RASH (Rashes on trunk (full body), arms and legs) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site nodule
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE NODULE (red knot under her injection site) and CHILLS (Chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced INJECTION SITE NODULE (red knot under her injection site) and CHILLS (Chills). At the time of the report, INJECTION SITE NODULE (red knot under her injection site) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Hip Ache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Hip Ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced ARTHRALGIA (Hip Ache). At the time of the report, ARTHRALGIA (Hip Ache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Headache, Hypoaesthesia, Malaise
Clinical narrative: Chest did not feel to good and Tight on the chest; Short of breath; With some numbness; Back of their neck hurts; Don't fell good; Reaction to the vaccine; Headaches, their head feels heavy; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest did not feel to good and Tight on the chest), DYSPNOEA (Short of breath), HYPOAESTHESIA (With some numbness), NECK PAIN (Back of their neck hurts) and MALAISE (Don't fell good) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced CHEST DISCOMFORT (Chest did not feel to good and Tight on the chest), DYSPNOEA (Short of breath), HYPOAESTHESIA (With some numbness), NECK PAIN (Back of their neck hurts), MALAISE (Don't fell good), VACCINATION COMPLICATION (Reaction to the vaccine) and HEADACHE (Headaches, their head feels heavy). At the time of the report, CHEST DISCOMFORT (Chest did not feel to good and Tight on the chest), DYSPNOEA (Short of breath), HYPOAESTHESIA (With some numbness), NECK PAIN (Back of their neck hurts), MALAISE (Don't fell good), VACCINATION COMPLICATION (Reaction to the vaccine) and HEADACHE (Headaches, their head feels heavy) outcome was unknown.            No concomitant medications were provided. Treatment medications were unknown.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Vaccination complication
Clinical narrative: Chest did not feel to good and Tight on the chest; Short of breath; With some numbness; Back of their neck hurts; Don't fell good; Reaction to the vaccine; Headaches, their head feels heavy; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest did not feel to good and Tight on the chest), DYSPNOEA (Short of breath), HYPOAESTHESIA (With some numbness), NECK PAIN (Back of their neck hurts) and MALAISE (Don't fell good) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced CHEST DISCOMFORT (Chest did not feel to good and Tight on the chest), DYSPNOEA (Short of breath), HYPOAESTHESIA (With some numbness), NECK PAIN (Back of their neck hurts), MALAISE (Don't fell good), VACCINATION COMPLICATION (Reaction to the vaccine) and HEADACHE (Headaches, their head feels heavy). At the time of the report, CHEST DISCOMFORT (Chest did not feel to good and Tight on the chest), DYSPNOEA (Short of breath), HYPOAESTHESIA (With some numbness), NECK PAIN (Back of their neck hurts), MALAISE (Don't fell good), VACCINATION COMPLICATION (Reaction to the vaccine) and HEADACHE (Headaches, their head feels heavy) outcome was unknown.            No concomitant medications were provided. Treatment medications were unknown.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Vaccination site erythema, Vaccination site mass, Vaccination site pruritus
Clinical narrative: redness is getting wider; it's all red around; it's itchy; had a little lump on the injection site; had a little headache; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness is getting wider), VACCINATION SITE MASS (had a little lump on the injection site), HEADACHE (had a little headache), VACCINATION SITE ERYTHEMA (it's all red around) and VACCINATION SITE PRURITUS (it's itchy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation and Osteoporosis.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE MASS (had a little lump on the injection site) and HEADACHE (had a little headache). On 20-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (it's all red around) and VACCINATION SITE PRURITUS (it's itchy). On an unknown date, the patient experienced ERYTHEMA (redness is getting wider). On 13-Feb-2021, VACCINATION SITE MASS (had a little lump on the injection site) and HEADACHE (had a little headache) had resolved. At the time of the report, ERYTHEMA (redness is getting wider), VACCINATION SITE ERYTHEMA (it's all red around) and VACCINATION SITE PRURITUS (it's itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided. Treatment medication was not reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Non significant follow up.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site warmth, Myalgia, Vaccination site erythema
Clinical narrative: Arm hot to touch; Chills; Muscle and arm aches; Redness at vaccine site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Arm hot to touch), CHILLS (Chills), MYALGIA (Muscle and arm aches) and VACCINATION SITE ERYTHEMA (Redness at vaccine site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced INJECTION SITE WARMTH (Arm hot to touch), CHILLS (Chills), MYALGIA (Muscle and arm aches) and VACCINATION SITE ERYTHEMA (Redness at vaccine site). At the time of the report, INJECTION SITE WARMTH (Arm hot to touch), CHILLS (Chills), MYALGIA (Muscle and arm aches) and VACCINATION SITE ERYTHEMA (Redness at vaccine site) had resolved.            Details reported by phone on follow-up: patient said all AE's dissipated within 2 weeks, that she is feeling fine now and has nothing else to report.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: No specific follow-up information recorded.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: her arm is red; arm started itching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm started itching) and ERYTHEMA (her arm is red) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PRURITUS (arm started itching). On an unknown date, the patient experienced ERYTHEMA (her arm is red). At the time of the report, PRURITUS (arm started itching) and ERYTHEMA (her arm is red) outcome was unknown.            treatment medication include calamine lotion, Benadryl no concomitant medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: contact  information was updated
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site warmth
Clinical narrative: pain; hot at the touch; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) and VACCINATION SITE WARMTH (hot at the touch) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (pain) and VACCINATION SITE WARMTH (hot at the touch). At the time of the report, PAIN (pain) and VACCINATION SITE WARMTH (hot at the touch) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-018154 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Injection site pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0L0M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced INJECTION SITE PAIN (Injection site pain). At the time of the report, INJECTION SITE PAIN (Injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication were provided. No concomitant medication were provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Thirst, Tremor
Clinical narrative: Uncontrollable shaking; Thirsty; Tired; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Uncontrollable shaking), THIRST (Thirsty) and FATIGUE (Tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced TREMOR (Uncontrollable shaking), THIRST (Thirsty) and FATIGUE (Tired). On 03-Feb-2021, TREMOR (Uncontrollable shaking) had resolved. At the time of the report, THIRST (Thirsty) and FATIGUE (Tired) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included thyroid medication.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-027392 (E2B Linked Report). This case was linked to MOD-2021-023862 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-027392:Crosslinked (MOD21-021326)
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: a week later she had it again, hotter than the first time; now it itches; a red spot on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (a week later she had it again, hotter than the first time), VACCINATION SITE PRURITUS (now it itches) and VACCINATION SITE ERYTHEMA (a red spot on the injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (a red spot on the injection site). On 03-Feb-2021, the patient experienced VACCINATION SITE WARMTH (a week later she had it again, hotter than the first time) and VACCINATION SITE PRURITUS (now it itches). At the time of the report, VACCINATION SITE WARMTH (a week later she had it again, hotter than the first time), VACCINATION SITE PRURITUS (now it itches) and VACCINATION SITE ERYTHEMA (a red spot on the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: rash/quarter size rash; very painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (very painful) and VACCINATION SITE RASH (rash/quarter size rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), MULTIVITAMIN [VITAMINS NOS] and PROBIOTICS NOS for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE PAIN (very painful). On 01-Feb-2021, the patient experienced VACCINATION SITE RASH (rash/quarter size rash). On 27-Jan-2021, VACCINATION SITE PAIN (very painful) had resolved. At the time of the report, VACCINATION SITE RASH (rash/quarter size rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Patient date of birth was mentioned This case was linked to MOD-2021-228430 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow up received on 18-June-2021  contains information on first dose event outcome, second dose and events after that, separate case created for second dose. On 18-Jun-2021: Follow up received on 18-June-2021 does not contain any significant information.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Lethargy
Clinical narrative: Chills; Fever (Not Measured); Extreme Headache; Extreme Fatigue; Not Feeling Like Himself; Lethargic; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not Feeling Like Himself), LETHARGY (Lethargic), CHILLS (Chills), PYREXIA (Fever (Not Measured)) and HEADACHE (Extreme Headache) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 30-Dec-2020, the patient experienced LETHARGY (Lethargic). On 30-Jan-2021, the patient experienced FEELING ABNORMAL (Not Feeling Like Himself), CHILLS (Chills), PYREXIA (Fever (Not Measured)), HEADACHE (Extreme Headache) and FATIGUE (Extreme Fatigue). On 02-Feb-2021, FEELING ABNORMAL (Not Feeling Like Himself), LETHARGY (Lethargic), CHILLS (Chills), PYREXIA (Fever (Not Measured)), HEADACHE (Extreme Headache) and FATIGUE (Extreme Fatigue) had resolved.            No concomitant medications reported by investigator No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up information received on 21-MAY-2021 contains non-significant information.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills; Fever (Not Measured); Extreme Headache; Extreme Fatigue; Not Feeling Like Himself; Lethargic; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not Feeling Like Himself), LETHARGY (Lethargic), CHILLS (Chills), PYREXIA (Fever (Not Measured)) and HEADACHE (Extreme Headache) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 30-Dec-2020, the patient experienced LETHARGY (Lethargic). On 30-Jan-2021, the patient experienced FEELING ABNORMAL (Not Feeling Like Himself), CHILLS (Chills), PYREXIA (Fever (Not Measured)), HEADACHE (Extreme Headache) and FATIGUE (Extreme Fatigue). On 02-Feb-2021, FEELING ABNORMAL (Not Feeling Like Himself), LETHARGY (Lethargic), CHILLS (Chills), PYREXIA (Fever (Not Measured)), HEADACHE (Extreme Headache) and FATIGUE (Extreme Fatigue) had resolved.            No concomitant medications reported by investigator No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow-up information received on 21-MAY-2021 contains non-significant information.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia
Clinical narrative: difficulty swallowing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPHAGIA (difficulty swallowing) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041620A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPHAGIA (difficulty swallowing). At the time of the report, DYSPHAGIA (difficulty swallowing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were provided by reporter  No treatment was reported
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Urticaria, Vaccination site pain
Clinical narrative: Hives on her neck, chest, breast area, and lower abdomen; A red patch on her neck; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm soreness), URTICARIA (Hives on her neck, chest, breast area, and lower abdomen) and ERYTHEMA (A red patch on her neck) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm soreness). On 22-Feb-2021, the patient experienced URTICARIA (Hives on her neck, chest, breast area, and lower abdomen) and ERYTHEMA (A red patch on her neck). At the time of the report, VACCINATION SITE PAIN (Arm soreness), URTICARIA (Hives on her neck, chest, breast area, and lower abdomen) and ERYTHEMA (A red patch on her neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment for the event included hydrocortizone cream.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Diarrhea; Headache; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Congestive heart failure. Concurrent medical conditions included Rheumatoid arthritis.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills). At the time of the report, DIARRHOEA (Diarrhea), HEADACHE (Headache), FATIGUE (Fatigue) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided No treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow-up received on 09-Jul-2021 contains significant information event outcome updated(From unknown to recovered)
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: red spot; swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red spot) and VACCINATION SITE SWELLING (swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red spot) and VACCINATION SITE SWELLING (swelling). At the time of the report, VACCINATION SITE ERYTHEMA (red spot) and VACCINATION SITE SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication not provided.  Treatment details included Topical anti-inflammatory medications.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash macular, Rosacea, Urticaria
Clinical narrative: Rosacea on my face; a new itchy spot on her arm; several "blotches"; red places on both arms and collar bone; another "spot" developed on her arm; started itching; left arm started to "Get itchy"; red puffy, welts on her right arm (2" in diameter); big round red mark ("spot") at the injection site; itchy; COVID Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID Arm), PRURITUS (a new itchy spot on her arm), ERYTHEMA (red places on both arms and collar bone) and ROSACEA (Rosacea on my face) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 47A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX, FLU VACCINE VII and PNEUMOCOCCAL VACCINE (Pneumonia Vaccine). Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE REACTION (COVID Arm). On 22-Feb-2021, the patient experienced PRURITUS (a new itchy spot on her arm) and ERYTHEMA (red places on both arms and collar bone). On an unknown date, the patient experienced ROSACEA (Rosacea on my face). The patient was treated with STEROIDS from 23-Feb-2021 to 01-Mar-2021 at a dose of UNK milligram. On 23-Feb-2021, PRURITUS (a new itchy spot on her arm) and ERYTHEMA (red places on both arms and collar bone) had resolved. At the time of the report, VACCINATION SITE REACTION (COVID Arm) had resolved and ROSACEA (Rosacea on my face) was resolving.            Treatment:  Ice, anti-itch powder, Aveeno anti-itch cream, Metronidazole 0.75%   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: VAERS form On 22-Jun-2021: Significant Follow up information received, new event added
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: Rosacea on my face; a new itchy spot on her arm; several "blotches"; red places on both arms and collar bone; another "spot" developed on her arm; started itching; left arm started to "Get itchy"; red puffy, welts on her right arm (2" in diameter); big round red mark ("spot") at the injection site; itchy; COVID Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID Arm), PRURITUS (a new itchy spot on her arm), ERYTHEMA (red places on both arms and collar bone) and ROSACEA (Rosacea on my face) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 47A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: SHINGRIX, FLU VACCINE VII and PNEUMOCOCCAL VACCINE (Pneumonia Vaccine). Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE REACTION (COVID Arm). On 22-Feb-2021, the patient experienced PRURITUS (a new itchy spot on her arm) and ERYTHEMA (red places on both arms and collar bone). On an unknown date, the patient experienced ROSACEA (Rosacea on my face). The patient was treated with STEROIDS from 23-Feb-2021 to 01-Mar-2021 at a dose of UNK milligram. On 23-Feb-2021, PRURITUS (a new itchy spot on her arm) and ERYTHEMA (red places on both arms and collar bone) had resolved. At the time of the report, VACCINATION SITE REACTION (COVID Arm) had resolved and ROSACEA (Rosacea on my face) was resolving.            Treatment:  Ice, anti-itch powder, Aveeno anti-itch cream, Metronidazole 0.75%   Most recent FOLLOW-UP information incorporated above includes: On 05-May-2021: VAERS form On 22-Jun-2021: Significant Follow up information received, new event added
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Oral discomfort, Pruritus
Clinical narrative: Burning in his lips; Itching in the palms of my hands, waist area, and genital area; This spontaneous case was reported by an other health care professional and describes the occurrence of ORAL DISCOMFORT (Burning in his lips) and PRURITUS (Itching in the palms of my hands, waist area, and genital area) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Peanut allergy (On one occasion years ago).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced ORAL DISCOMFORT (Burning in his lips) and PRURITUS (Itching in the palms of my hands, waist area, and genital area). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Symptomatic treatment, at a dose of 50 milligram. On 04-Feb-2021, ORAL DISCOMFORT (Burning in his lips) and PRURITUS (Itching in the palms of my hands, waist area, and genital area) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.   The patient reported having no allergic reaction to the vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Follow-up received on 04-Jun-2021: Provided patient's medical history. On 03-Jul-2021: Follow-up received on 03-Jul-2021: Contains no significant information.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain
Clinical narrative: little tenderness in the same arm  at the injection and a little hard; initial pain and little tenderness in the same arm at the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (little tenderness in the same arm  at the injection and a little hard) and VACCINATION SITE PAIN (initial pain and little tenderness in the same arm at the injection) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure high and Thyroid disorder NOS. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE INDURATION (little tenderness in the same arm  at the injection and a little hard) and VACCINATION SITE PAIN (initial pain and little tenderness in the same arm at the injection). At the time of the report, VACCINATION SITE INDURATION (little tenderness in the same arm  at the injection and a little hard) and VACCINATION SITE PAIN (initial pain and little tenderness in the same arm at the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also included high blood pressure(advil), slow thyroid  every day. Treatment for the event was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Gout
Clinical narrative: gout in left ankle; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (gout in left ankle) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced GOUT (gout in left ankle). At the time of the report, GOUT (gout in left ankle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fall, Myalgia, Nausea
Clinical narrative: fell in shower; Sore Throat; fever of 101 degrees Fahrenheit; Nausea; Chills; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of FALL (fell in shower), OROPHARYNGEAL PAIN (Sore Throat), PYREXIA (fever of 101 degrees Fahrenheit), NAUSEA (Nausea) and CHILLS (Chills) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced FALL (fell in shower), OROPHARYNGEAL PAIN (Sore Throat), PYREXIA (fever of 101 degrees Fahrenheit), NAUSEA (Nausea), CHILLS (Chills) and MYALGIA (Soreness). At the time of the report, FALL (fell in shower), OROPHARYNGEAL PAIN (Sore Throat), PYREXIA (fever of 101 degrees Fahrenheit), NAUSEA (Nausea), CHILLS (Chills) and MYALGIA (Soreness) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: high (High) 101 degrees Fahrenheit.         No concomitant medications were provided No treatment information provided